Morgenthaler Ventures

Morgenthaler is a venture capital and buyout firm that has worked with entrepreneurs to build companies for more than 40 years. Today, the firm has nearly $3 billion under management, including $450 million in its ninth and current fund, MVP IX, capitalized in November of 2008. Morgenthaler is headquartered in Menlo Park, CA, with offices in Boulder, CO; Boston; and Cleveland, OH. The Boston office engages in both Life Sciences Venture and Buyout activities. Morgenthaler's Boston and Cleveland-based buyout group focuses on traditional management buyouts and leveraged recapitalizations, industry build-ups and later-stage investments, targeting profitable, stand-alone middle-market companies, and divisions or subsidiaries of larger corporations. The Buyout group focuses on high-value manufacturing and business services. The firm expects to invest between $5 and $15 million total in each information technology company, between $12 and $20 million in each biotech company, and between $12 and $15 million in each device company over several rounds. Initial investments can be as small as $500 thousand. Within information technology, Morgenthaler invests accross a broad spectrum of life sciences companies, particularly those in the fields of: Therapeutic Biopharmaceuticals and Medical Devices.